Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group. Photo: Handout

China’s Fosun Pharma to bypass India’s regulatory hurdles after cutting stake in Gland Pharma deal

Chinese drug maker to cut the stake it wants to buy in India’s Gland Pharma to ensure faster regulatory approvals

TOP PICKS

Wu Yifang, president and CEO of Shanghai Fosun Pharmaceutical Group. Photo: Handout
READ FULL ARTICLE